Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis. (October 2022)
- Record Type:
- Journal Article
- Title:
- Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis. (October 2022)
- Main Title:
- Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis
- Authors:
- Berek, Klaus
Hegen, Harald
Hocher, Jakob
Auer, Michael
Di Pauli, Franziska
Krajnc, Nik
Angermann, Reinhard
Barket, Robert
Zinganell, Anne
Riedl, Katharina
Deisenhammer, Florian
Berger, Thomas
Bsteh, Gabriel - Abstract:
- Background: Peripapillary retinal nerve fibre layer and macular ganglion cell plus inner plexiform layer thinning are markers of neuroaxonal degeneration in multiple sclerosis. Objective: We aimed to investigate the value of peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer thinning for prediction of long-term disability. Methods: This is a 6-year prospective longitudinal study on 93 multiple sclerosis patients. Optical coherence tomography scans were performed at baseline, after 1, 2 and 6 years. Primary endpoint was disability progression after 6 years, defined as expanded disability status scale worsening and/or cognitive deterioration. Univariate and multivariate analysis was used to investigate the value of peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer to predict the primary endpoint. Results: A total of 57 (61.3%) patients had disability worsening, 40 (43.0%) expanded disability status scale worsening and 34 (36.6%) cognitive deterioration. Mean peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer baseline thickness were 93.0 and 75.2 µm, and mean annualised peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer thinning rates over 6 years were 1.3 and 1.6 µm, respectively. Univariate and multivariate analysis revealed lower peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer baseline thickness andBackground: Peripapillary retinal nerve fibre layer and macular ganglion cell plus inner plexiform layer thinning are markers of neuroaxonal degeneration in multiple sclerosis. Objective: We aimed to investigate the value of peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer thinning for prediction of long-term disability. Methods: This is a 6-year prospective longitudinal study on 93 multiple sclerosis patients. Optical coherence tomography scans were performed at baseline, after 1, 2 and 6 years. Primary endpoint was disability progression after 6 years, defined as expanded disability status scale worsening and/or cognitive deterioration. Univariate and multivariate analysis was used to investigate the value of peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer to predict the primary endpoint. Results: A total of 57 (61.3%) patients had disability worsening, 40 (43.0%) expanded disability status scale worsening and 34 (36.6%) cognitive deterioration. Mean peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer baseline thickness were 93.0 and 75.2 µm, and mean annualised peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer thinning rates over 6 years were 1.3 and 1.6 µm, respectively. Univariate and multivariate analysis revealed lower peripapillary retinal nerve fibre layer and ganglion cell plus inner plexiform layer baseline thickness and higher annualised thinning rates in patients with disability progression after 6 years. Effects were more pronounced for ganglion cell plus inner plexiform layer and expanded disability status scale worsening than for peripapillary retinal nerve fibre layer models and cognitive deterioration. Conclusion: Ganglion cell plus inner plexiform layer and peripapillary retinal nerve fibre layer measurements depict neurodegeneration and predict disability progression in multiple sclerosis. … (more)
- Is Part Of:
- Multiple sclerosis. Volume 28:Number 12(2022)
- Journal:
- Multiple sclerosis
- Issue:
- Volume 28:Number 12(2022)
- Issue Display:
- Volume 28, Issue 12 (2022)
- Year:
- 2022
- Volume:
- 28
- Issue:
- 12
- Issue Sort Value:
- 2022-0028-0012-0000
- Page Start:
- 1871
- Page End:
- 1880
- Publication Date:
- 2022-10
- Subjects:
- Multiple sclerosis -- biomarker -- optical coherence tomography -- GCIPL -- pRNFL -- stable -- progressive
Central nervous system -- Diseases -- Periodicals
Myelin sheath -- Diseases -- Periodicals
Inflammation -- Periodicals
Multiple sclerosis -- Periodicals
Central Nervous System Diseases -- Periodicals
Demyelinating Diseases -- Periodicals
Inflammation -- Periodicals
Multiple Sclerosis -- Periodicals
Système nerveux central -- Maladies -- Périodiques
Gaine de myéline -- Maladies -- Périodiques
Inflammation (Pathologie) -- Périodiques
Sclérose en plaques -- Périodiques
Electronic journals
616.834005 - Journal URLs:
- http://msj.sagepub.com/ ↗
http://search.ebscohost.com/login.aspx?direct=true&db=a2h&jid=DZL&site=ehost-live ↗
http://www.uk.sagepub.com/home.nav ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1352-4585;screen=info;ECOIP ↗
http://www.arnoldpublishers.com/journals/pages/mul_scl/13524585.htm ↗ - DOI:
- 10.1177/13524585221097566 ↗
- Languages:
- English
- ISSNs:
- 1352-4585
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22998.xml